Sector
1090 stories · page 48 of 55
“Looking ahead, the group is well placed to accelerate its commercialisation plans through the three partnerships it struck within its discovery science division and the launch of its innovative app portfolio in the US from its software pro
The ice hockey team have added Binovi’s vision training to their programs to improve the vision and overall performance of each player
Initial testing took place using Beckman Coulter Life Sciences' chemistry on respiratory swabs in conjunction with gendrive’s 96 SARS-CoV-2 equipment
The pair will seek to better understand and compare the altered states of consciousness induced by psilocybin and LSD
In its latest research, the US broker rates the shares a 'buy' and values them at U$11 each
The drug repurposing firm said the DSMB had unanimously approved the continuation of the study
The collaboration ramps up lenzilumab manufacturing capacity ahead of anticipated Emergency Use Authorization for the drug in 2020
After completing their analysis, the DSMB recommended that the trial continue according to the existing trial protocol without modification
The funds will help expand MagicMed’s Psybrary, a molecular derivatives library designed to be a key platform for the psychedelics industry to develop new patented products
The trial is for the potential treatment of methamphetamine use disorder
Empower Clinics CEO Steven McAuley said Kai has a "newly built high-complexity lab offering a wide array of testing services, that together we will leverage to serve the massive demand" for COVID testing in the US
In May, Health Canada approved esketamine — an altered form of ketamine — for the treatment of major depressive disorder
Approximately 20%of the targeted assessable patients have been treated since the initiation of the trial.
The e-commerce firm put the strong performance of the Nature's Exclusive brand down to the fact it has added innovative products and made "significant" investment in customer acquisition
The trial is scheduled to start in the fourth quarter at the University Hospital Basel's Liechti Lab in Switzerland
For the period ended June 30, 2020, the group clocked up revenue of $923,876 driven by 6,696 patient visits
The group has finalized the deal with Unified Funding LLC’s wholly owned subsidiary Offer Space LLC to acquire the asset for US$1 million
Golden Path and Wild Mariposa join a growing portfolio of names under the Thoughtful Brands umbrella, including Nature’s Exclusive in North America and Sativida in Spain and Mexico
Both Golden Path and Wild Mariposa are direct-to-consumer eCommerce brands selling a range of natural health products, including nutraceutical and hemp-based CBD
The company said it believes that the name and symbol change better reflect the success of its strategic growth and its drive to acquire and develop branded products and research initiatives in the natural health products space
